Dublin, Feb. 06, 2017 -- Research and Markets has announced the addition of the "Global Ophthalmic Devices Market Analysis & Trends - Industry Forecast to 2025" report to their offering.
The Global Ophthalmic Device Market is poised to grow at a CAGR of around 4.8% over the next decade to reach approximately $71.9 billion by 2025. Some of the prominent trends that the market is witnessing include increasing elderly population, rising frequency of everyday life related diseases, growing relevance of technology in ophthalmology, growth opportunities/investment opportunities.
Based on end users the market is categorized into hospitals, academic and research laboratories and other end users. As per application the market is segmented into cataract, vitreo retinal disorders, glaucoma and refractor disorders.
Depending on product the market is categorized into vision care, surgery devices and diagnostic and monitoring devices. Vision care includes contact lenses and spectacles. Surgery devices include vitreoretinal surgery devices, refractive surgery devices, cataract surgery devices and glaucoma surgery devices. Diagnostic and monitoring devices further segmented into autorefractors/phoropters, fundus cameras, corneal topographer, keratometers, ophthalmic ultrasound imaging systems, ophthalmoscopes, optical coherence tomography scanners, perimeters/visual field analyzers, retinoscopes, slit lamps, specular microscopes, tonometers, pachymeter and wavefront aberrometers.
Report Highlights:
- The report provides a detailed analysis on current and future market trends to identify the investment opportunities;
- Market forecasts till 2025, using estimated market values as the base numbers;
- Key market trends across the business segments, Regions and Countries;
- Key developments and strategies observed in the market;
- Market Dynamics such as Drivers, Restraints, Opportunities and other trends;
- In-depth company profiles of key players and upcoming prominent players;
- Growth prospects among the emerging nations through 2025;
- Market opportunities and recommendations for new investments.
Companies Mentioned:
- CooperVision AG.
- Abbott Medical Optics, Inc.
- Alcon, Inc.
- Bausch & Lomb, Inc.
- Canon Inc
- Carl Zeiss Meditec AG
- Essilor International S.A.
- HAAG-Streit Group
- Hoya Corporation
- Johnson & Johnson
- Nidek Co., Ltd.
- Novartis AG
- Topcon Corporation
- VisionCare
- Ziemer Ophthalmic Systems AG
Key Topics Covered:
1 Market Outline
2 Executive Summary
3 Market Overview
4 Ophthalmic Devices Market, By End Users
5 Ophthalmic Devices Market, By Application
6 Ophthalmic Devices Market, By Product
7 Ophthalmic Devices Market, By Geography
8 Key Player Activities
9 Leading Companies
For more information about this report visit http://www.researchandmarkets.com/research/lz84mx/global_ophthalmic
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Optical


Boeing Wins $2.04B U.S. Air Force Contract for B-52 Engine Replacement Program
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026
Moore Threads Unveils New GPUs, Fuels Optimism Around China’s AI Chip Ambitions
Waymo Plans Safety and Emergency Response Upgrades After San Francisco Robotaxi Disruptions
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies
Uber and Baidu Partner to Test Robotaxis in the UK, Marking a New Milestone for Autonomous Ride-Hailing
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio
South Korean Court Clears Korea Zinc’s $7.4 Billion U.S. Smelter Project, Shares Surge
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift
Hanwha Signals Readiness to Build Nuclear-Powered Submarines at Philly Shipyard for U.S. Navy
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage
Hyundai Recalls Over 51,000 Vehicles in the U.S. Due to Fire Risk From Trailer Wiring Issue 



